Evidence map›Paper›PMID 35672148›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2022

Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the

Qian Shi, Cheng Chang, Afaf Saliba, Manzoor A Bhat

Open access · greenAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 1 pooled it
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 1 synthesis or guideline pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Native PLGA nanoparticles attenuate disease pathology via multiple pathways in 5xFAD Alzheimer's model.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. PTP1B inhibition promotes microglial phagocytosis in Alzheimer's disease models by enhancing SYK signaling.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Microglial phagocytosis in Alzheimer disease.Nature reviews. Neurology · 2026
    Review
  17. Review
  18. TREM2-driven peripheral macrophage regulation in inflammatory diseases: implications extending beyond neurological disorders.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  19. Article
  20. Roles of TREM2 in Alzheimer's disease.Translational neurodegeneration · 2025
    Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Qian ShiDepartment of Cellular and Integrative Physiology, Long School of Medicine, University of Texas Health Science Center, San Antonio, Texas 78229.
Cheng ChangDepartment of Cellular and Integrative Physiology, Long School of Medicine, University of Texas Health Science Center, San Antonio, Texas 78229.
Afaf SalibaDepartment of Cellular and Integrative Physiology, Long School of Medicine, University of Texas Health Science Center, San Antonio, Texas 78229.ORCID https://orcid.org/0000-0003-2576-4069
Manzoor A BhatDepartment of Cellular and Integrative Physiology, Long School of Medicine, University of Texas Health Science Center, San Antonio, Texas 78229 bhatm@uthscsa.edu.ORCID https://orcid.org/0000-0003-0989-1498
The University of Texas Health Science Center at San Antonio · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mechanistic target of rapamycin (mTOR) signaling pathway plays a major role in key cellular processes including metabolism and differentiation; however, the role of mTOR in microglia and its importance in Alzheimer's disease (AD) have remained largely uncharacterized. We report that selective loss of

Indexed as

Alzheimer DiseaseMembrane GlycoproteinsPlaque, AmyloidReceptors, ImmunologicAmyloid beta-PeptidesAnimalsDisease Models, AnimalFemaleMaleMiceMice, TransgenicMicrogliaSirolimusTOR Serine-Threonine KinasesAmyloid beta-PeptidesMembrane GlycoproteinsReceptors, ImmunologicSirolimusTOR Serine-Threonine KinasesTrem2 protein, mouseAlzheimer's diseasemicrogliamTORrapamycinTrem2β-amyloid

Identifiers

PMID35672148
PMCPMC9270922
OpenAlexW4281762328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.